The New York Times – Business:
A gene therapy for Duchenne muscular dystrophy caused complications to the liver, prompting a review of its use for younger patients.
The New York Times – Business:
A gene therapy for Duchenne muscular dystrophy caused complications to the liver, prompting a review of its use for younger patients.
The New York Times – Business:
Under the plan, the company will dissolve and its owners, members of the Sackler family, will pay as much as $7 billion of their personal fortune to states, localities, tribes and others harmed in the opioid crisis.
The New York Times – Business:
A Biden-era rule, now halted, would have forced airlines to pay passengers up to $775 in cash for significant flight disruptions.
The New York Times – Business:
Jobs and inflation data will be released late and with caveats, complicating the Federal Reserve’s interest rate deliberations.
The New York Times – Business:
When prosecutors accused Charlie Javice of fraud, JPMorgan was forced to pay for her defense. The bank is not happy about her “shocking” spending.
The New York Times – Business:
The exit by RedBird Capital Partners comes months after it agreed to buy control of the media company in a deal that valued it at $658 million.
The New York Times – Business:
Apple joined Google this week in allowing travelers to add their passports to their cellphone “wallets.” As the holiday travel season nears, here’s what you need to know.
The New York Times – Business:
The Trump administration is facing backlash from American consumers as higher costs from tariffs blunt wage gains.
The New York Times – Business:
The deal would reduce an extraordinarily high tariff rate that had threatened to cripple Swiss exports.
The New York Times – Business:
A recent dip in trading shows how investors are balancing a “fear of missing out at the same time as real fear.”